IRIS
GALATI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.724
NA - Nord America 545
EU - Europa 228
SA - Sud America 41
AF - Africa 13
OC - Oceania 6
Totale 4.557
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.272
US - Stati Uniti d'America 525
CN - Cina 271
HK - Hong Kong 116
GB - Regno Unito 61
IT - Italia 47
DE - Germania 35
BR - Brasile 28
VN - Vietnam 24
FI - Finlandia 19
CZ - Repubblica Ceca 15
NL - Olanda 15
CA - Canada 10
IN - India 10
PL - Polonia 10
FR - Francia 9
TR - Turchia 8
MX - Messico 7
ES - Italia 6
AR - Argentina 5
AU - Australia 5
ZA - Sudafrica 5
CL - Cile 4
PE - Perù 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BY - Bielorussia 2
JP - Giappone 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
TH - Thailandia 2
UA - Ucraina 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GN - Guinea 1
HT - Haiti 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
MU - Mauritius 1
SA - Arabia Saudita 1
SV - El Salvador 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.557
Salva come PNG Salva come JPEG
Città #
Singapore 203
Ashburn 140
Hong Kong 114
Hefei 103
Dallas 71
Beijing 70
Boardman 55
London 48
Shanghai 36
Munich 25
Rome 20
Council Bluffs 19
Los Angeles 17
Brno 15
Seattle 15
San Francisco 13
Santa Clara 12
Ho Chi Minh City 11
Turku 11
Amsterdam 10
São Paulo 10
West Jordan 10
Boston 9
New York 9
Warsaw 9
Helsinki 8
Washington 7
Mexico City 6
Pune 6
Sona 5
Toronto 5
Brooklyn 4
Guangzhou 4
Chicago 3
Haiphong 3
Johannesburg 3
Lima 3
Manchester 3
Montreal 3
Paris 3
Secaucus 3
Stockholm 3
Bangkok 2
Boydton 2
Camden 2
Canberra 2
Central 2
Hengshui 2
Kuala Lumpur 2
Melbourne 2
Naples 2
Orem 2
Poplar 2
Suffern 2
Tangshan 2
Tokyo 2
Zhengzhou 2
Almere Stad 1
Alvorada 1
Amman 1
Ankara 1
Atlanta 1
Augusta 1
Baku 1
Bihać 1
Brest 1
Brussels 1
Buffalo 1
Bắc Ninh 1
Camaçari 1
Cape Town 1
Carney 1
Casablanca 1
Chandigarh 1
Changchun 1
Chennai 1
City of London 1
Cleveland 1
Cold Lake 1
Conakry 1
Concepción 1
Curepipe 1
Curitiba 1
Da Nang 1
Delmas 1
Dharmapuri 1
Esteio 1
Foligno 1
Frankfurt am Main 1
Fuzhou 1
Gaborone 1
Gauteng 1
Genoa 1
Goiânia 1
Handan 1
Hangzhou 1
Hanoi 1
Hanover 1
Helena 1
Inhambupe 1
Totale 1.200
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 213
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 211
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 206
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 206
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 203
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 203
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 201
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 196
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 194
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 192
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 188
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 185
Assessment of liver function by the exhaled breath-print during chronic liver disease 183
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 173
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 138
Diabetes in chronic liver disease: from old concepts to new evidence 110
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 103
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 97
A challenging alfa-fetoprotein in a cirrhotic patient 96
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 94
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 92
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 90
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 90
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 83
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 62
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 37
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 37
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 36
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 36
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 36
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 35
Hepatic complications of bariatric surgery : the reverse side of the coin 34
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 34
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 32
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 32
Surgical complications after resection of adrenal carcinoma 31
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 30
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 30
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 30
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 28
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 26
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 26
GAS EXCHANGE AND PULMONARY MICROCIRCULATION ABNORMALITIES IN CIRRHOTIC AND NON-CIRRHOTIC CHRONIC LIVER DISEASE PATIENTS FREE FROM HEPATOPULMONARY SYNDROME 26
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 25
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 25
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 25
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 25
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 25
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 22
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 22
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis 20
Totale 4.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.612
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 4 0 0 2 0 0 5 0 0 72
2022/202333 6 0 1 1 0 2 9 4 0 1 9 0
2023/2024194 8 13 6 20 13 79 2 13 3 12 7 18
2024/20253.571 35 17 55 9 55 66 51 7 111 183 1.481 1.501
2025/2026693 169 81 112 145 83 103 0 0 0 0 0 0
Totale 4.574